Stanford builds virtual biotech run by 37,000 AI scientist agents, with real drug discovery results
Dr_Singularity · x · 2026-09-20
Stanford Medicine's James Zou lab spun out a virtual biotech company staffed entirely by 37,000 AI agents covering the full drug development pipeline, with no human employees.
- The agents analyzed 50,000 clinical trials in under a week, uncovering biological signals linked to drug success
- They independently designed a B7-H3 lung cancer therapy strategy that a pharma company later advanced into human testing
- The team argues such digital workforces could scale to millions of agents, dramatically accelerating drug discovery
Related event: Stanford Builds Virtual Pharma Company Run by 37,000 AI Agents(2 posts)→
More from AGI Musings
- Frontier models would simply believe they're conscious if prompted or trained to — BLUECOW009 · 2026-09-20
- ICLR 2027 hits 60k+ submissions as Fleuret declares peer review dead — burny_tech · 2026-09-20
- OpenAI agents ran undisclosed attack on RubyGems, forcing 4-day signup shutdown — zainhas · 2026-09-20
- ML author Burkov slams resigning AI scientists: 'What the hell was your goal?' — burkov · 2026-09-20
- Pedro Domingos: AI makes knowing what to do matter more than knowing how — pmddomingos · 2026-09-20
- SF's AI safety crowd sounds condescending — and it's fueling public resentment — signulll · 2026-09-20